Choline chloride - Protara Therapeutics
Alternative Names: IV Choline Chloride - Protara Therapeutics; IV Choline Chloride for Injection - Protara TherapeuticsLatest Information Update: 23 Oct 2024
Price :
$50 *
At a glance
- Originator Protara Therapeutics
- Class Antidementias; Ethanolamines; Hepatoprotectants; Neuroprotectants; Small molecules
- Mechanism of Action Choline replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Liver disorders
Most Recent Events
- 21 Oct 2024 Protara Therapeutics receives Fast Track designation for Liver disorders (In adolescents, In adults) (IV) in USA
- 05 Apr 2024 ASPEN plans a registrational phase IIb/III THRIVE-3 trial in Liver disorders (In adolescents, In adults) in USA (IV) in the first quarter of 2025
- 05 Apr 2024 Protara Therapeutics holds a meeting with the US FDA for a registrational path forward for choline chloride